Argent BioPharma Limited
RGT.L · LSE
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Market Cap | £13,911 | £1,145 | £964 | £855 |
| - Cash | £703 | £240 | £1,886 | £5,433 |
| + Debt | £1,045 | £575 | £4,353 | £6,018 |
| Enterprise Value | £14,253 | £1,480 | £3,430 | £1,439 |
| Revenue | £891 | £3,388 | £4,732 | £2,963 |
| % Growth | -73.7% | -28.4% | 59.7% | – |
| Gross Profit | £204 | £1,451 | £1,810 | £1,310 |
| % Margin | 22.9% | 42.8% | 38.3% | 44.2% |
| EBITDA | -£15,772 | -£20,122 | -£20,310 | -£14,576 |
| % Margin | -1,770% | -593.9% | -429.2% | -491.9% |
| Net Income | -£17,531 | -£20,824 | -£20,347 | -£15,870 |
| % Margin | -1,967.4% | -614.6% | -430% | -535.6% |
| EPS Diluted | -0.47 | -7.07 | -7.63 | -6.95 |
| % Growth | 93.4% | 7.3% | -9.8% | – |
| Operating Cash Flow | -£7,737 | £0 | £0 | £0 |
| Capital Expenditures | -£140 | -£190 | -£2,693 | -£3,327 |
| Free Cash Flow | -£14,402 | -£12,185 | -£14,851 | -£15,317 |